Palliative care and hospice in advanced heart failure

Journal of Palliative Medicine

Volumn 10, Issue 1, 2007, Pages 210-228

  Stuart, Brad ^a  

^a Sutter VNA and Hospice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART FAILURE; HOME CARE; HOSPICE CARE; HUMAN; INTERNET; PALLIATIVE THERAPY; PATHOGENESIS; PROGNOSIS; REVIEW; RISK ASSESSMENT; SYMPTOM; TREATMENT PLANNING;

ADVANCE CARE PLANNING; CONTINUITY OF PATIENT CARE; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HOSPICE CARE; HUMANS; PALLIATIVE CARE; PROGNOSIS; TERMINAL CARE;

EID: 33846898278     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2006.9988     Document Type: Review

References (157)

1. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ: Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.
2. Goff DC, Pandey DK, Chan FA, Ortiz C, Nichaman MZ: Congestive heart failure in the United States: Is there more than meets the I(CD Code)? The Corpus Christi Heart Project. Arch Intern Med 2000;160:197-202.
3. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D; Framingham Heart Study: Lifetime risk for developing congestive heart failure: The Framingham Heart Study. Circulation 2002;106:3068-3072.
4. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV: Prognosis and determinants of survival in patients newly diagnosed for heart failure. Arch Intern Med 2002;162:1689-1694.
5. Braunwald E. Shattuck Lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
6. Baker DW, Einstadter D, Thomas C, Cebul RD. Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. Am Heart J 2003;146:258-264.
7. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM: Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003;146:250-257.
8. Mehra MR, Greenberg BH: Cardiac resynchronization therapy: Caveat medicus? J Am Coll Cardiol 2004;43:1145-1148.
9. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
10. Miller LW: Listing criteria for cardiac transplantation: Results of an American Society for Transplant Physicians-National Institutes of Health conference. Transplantation 1998;66:947-951.
11. Goodlin SJ, Hauptman PJ, Arnold R, Grady K, Hershberger RE, Kutner J, Masoudi F, Spertus J, Dracup K, Cleary JF, Medak R, Crispell K, Pina I, Stuart B, Whitney C, Rector T, Teno J, Renlund DG: Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail 2004;10:200-209.
12. Hunt SA et al., for the Writing Committee: ACC/ AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. 〈www.acc.org/clinical/guidelines/failure/ index.pdf〉 (Last accessed June 20, 2006).
13. National Hospice and Palliative Care Organization: 〈www.nhpco.org/ files/public/2004NDSNational-SummaryStatsandTrends.pdf〉 (Last accessed June 20, 2006).
14. National Center for Health Statistics: 〈http://www. cdc.gov/nchs/data/hestat/preliminarydeaths04_ tables.pdf〉 (Last accessed June 30, 2006).
15. Lunney JR, Lynn J, Foley DL, Lipson S, Guralnik JM: Patterns of functional decline at the end of life. JAMA 2003;289:2387-2392.
16. Teno JM, Weitzen S, Fennell ML, Mor V: Dying trajectory in the last year of life: Does cancer trajectory fit other diseases? J Palliat Med 2001;4:457-464.
17. Tanvetyanon T, Leighton JC: Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer. Crit Care Med 2003;31:60-64.
18. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O'Connor CM: Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-1008.
19. Camici PG: Hibernation and heart failure. Heart 2004;90:141-143.
20. Wu L, Cooper L: Potential of the right ventricular endomyocardial biopsy to diagnose and assist in the management of congestive heart failure: Insights from recent clinical trials. Congest Heart Fail 2004;10:133-139.
21. Deschamps AM, Spinale FG: Disruptions and detours in the myocardial matrix highway and heart failure. Curr Hart Fail Rep 2005;2:10-17.
22. Cohn JN: New therapeutic strategies for heart failure: Left ventricular remodeling as the target. J Card Fail 2004;10(Suppl 6):S200-S201.
23. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Bonnet J, Clementy J, Roudaut R: Intraleft ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248-256.
24. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-1598.
25. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part 1: Diagnosis, prognosis, and measurement of diastolic function. Circulation 2002;105:1387-1393.
26. Vinch CS, Aurigemma GP, Hill JC, Gaasch WH, Volturo G, Tighe DA, Meyer TE: Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol 2003;91:1140-1143.
27. Thohan V: Prognostic implications of echocardiography in advanced heart failure. Curr Opin Cardiol 2004;19:238-249.
28. Aurigemma GP, Gaasch WH: Diastolic heart failure. N Engl J Med 2004;351:1097-1105.
29. Gheorghiade M, Gattis WA, O'Connor CM: Treatment gaps in the pharmacologic management of heart failure. Rev Cardiovasc Med 2002;3(Suppl 3):S11-S19.
30. Dolgin M (ed), and the Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. Boston: Little, Brown Medical Division, 1994.
31. Archana R, Gray D: The quality of life in chronic disease: Heart failure is as bad as it gets. Eur Heart J 2002;23:1806-1808.
32. Adams KF, Zannad F: Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998;135:S204-S215.
33. Stevenson LW, Perloff, JK: The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-888.
34. Drazner MH, Rame JE, Stevenson LW, Dries DL: Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581.
35. Economides E, Stevenson LW: The jugular veins: Knowing enough to look. Am heart J 1998;136:6-9.
36. Sochowski RA, Dubbin JD, Naqvi SZ: Clinical and hemodynamic assessment of the hepatojugular reflux. Am J Cardiol 1990;66:1002-1006.
37. Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW: Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant 1999;18:1126-1132.
38. Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Calusen H: Dying of lung cancer or cardiac failure: Prospective qualitative interview study of patients and their carers in the community. BMJ 2002;325:929-934.
39. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, Murabito JM, Vasan RS: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402.
40. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ: More "malignant" than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Failure 2001;3:315-322.
41. Lynn J: An 88-year-old woman facing the end of life. JAMA 1997;277:1633-1640.
42. Huikuri HV, Castellanos A, Myerburg RJ: Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
43. Koilpillai C, Quinones MA, Greenberg B Limacher MC, Shindler D, Pratt CM, Benedict CR, Kopelen H, Shelton B: Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol 1996;77:606-611.
44. Goldberger Z, Lampert R: Implantable cardioverter-defibrillators: Expanding indications and technologies. JAMA 2006;295:809-818.
45. Eichhorn EJ: Prognosis determination in heart failure. Am J Med 2001;110(Suppl 7A):14S-36S.
46. Stevenson WG, Stevenson LW: Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001;12:112-114.
47. Kao W, Costanzo MR: Prognosis determination in patients with advanced heart failure. J Heart Lung Transplant 1997;16:S2-S6.
48. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators: Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 2005;293:572-580.
49. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M: The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433.
50. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV: Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 2003;290:2581-2587.
51. Anker SD, Sharma R: The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.
52. Florea VG, Henein MY, Rauchhaus M, Koloczek V, Sharma R, Doehner W, Poole-Wilson PA, Coats AJ, Anker SD: The cardiac component of cardiac cachexia. Am Heart J 2002;144:45-50.
53. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ: The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2000;36:523-528.
54. Bradley TD, Floras JS: Sleep apnea and heart failure: Part II: central sleep apnea. Circulation 2003;107:1822-1826.
55. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435-1440.
56. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS; CANPAP Investigators: Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033.
57. Williams SA, Kasl SV, Heiat A, Abramson JL, Krumholz HM, Vaccarino V: Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002;64:6-12.
58. Vaccarino V, Kasl SV, Abramson J, Krumholz HM: Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001;38:199-205.
59. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O'Connor CM: Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004;110:3452-3456.
60. Sullivan MD, Levy WC, Crane BA, Russo JE, Spertus JA: Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004;94:1577-1580.
61. Joynt KE, Whellan DJ, O'connor CM: Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004;10:258-271.
62. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004;110:1780-1786.
63. Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, Hori M, Lim YJ, Mishima M, Masuyama T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004;43:55-60.
64. Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, Redfield MM, Burnett JC Jr. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail 2002;8:149-154.
65. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U: Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002;40:718-722.
66. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-641.
67. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A: Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005;294:1240-1247.
68. Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group: Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003;289:712-718.
69. Formiga F, Chivite D, Ortega C, Casas S, Ramon JM, Pujol R: End-of-life preferences in elderly patients admitted for heart failure. Q J Med 2004;97:803-808.
70. Haydar ZR, Lowe AJ, Kahveci KL, Weatherford W, Finucane T: Differences in end-of-life preferences between congestive heart failure and dementia in a medical house calls program. J Am Geriatr Soc 2004;52:736-740.
71. Sulmasy DP, Terry PB, Weisman CS, Miller DJ, Stallings RY, Vettese MA, Haller KB: The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 1998;128:621-629.
72. Rogers AE, Addington-Hall JM, Abery AJ, McCoy AS, Bulpitt C, Coats AJ, Gibbs JS: Knowledge and communication difficulties for patients with chronic heart failure: Qualitative study. BMJ 2000;321:605-607.
73. Wehby D, Brenner PS: Perceived learning needs of patients with heart failure. Heart Lung 1999;28:31-40.
74. McCarthy M, Hall JA, Ley M: Communication and choice in dying from heart disease. J R Soc Med 1997;90:128-131.
75. Hauptman PJ, Rector TS, Wentworth D, Kubo S: Quality of life in advanced heart failure: role of mitral regurgitation. Am Heart J 2006;151:213-218.
76. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA; Cardiovascular Outcomes Research Consortium: Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail 2004;10:368-373.
77. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS: The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000;48(5 Suppl):S101-S109.
78. Krumholz HM, Phillips RS, Hamel MB, Teno JM, Bellamy P, Broste SK, Califf RM, Vidaillet H, Davis RB, Muhlbaier LH, Connors AF Jr, Lynn J, Goldman L: Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation 1998;98:648-655.
79. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E: Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail 2000;6:225-232.
80. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW: Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-1024.
81. American Thoracic Society. Dyspnea: Mechanisms, assessment and management: A consensus statement. Am J Respir Crit Care Med 1999;159:321-340.
82. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW: Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987;136:58-61.
83. Manning HL, Schwartzstein RM: Pathophysiology of dyspnea. N Engl J Med 1995;333:1547-1553.
84. Carter JR, Sauder CL, Ray CA: Effect of morphine on sympathetic nerva activity in humans. J Appl Physiol 2002;93:1764-1769.
85. Vismara LA, Leaman DM, Zelis R: The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976;54:335-337.
86. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE: A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-944.
87. Cohen MH, Anderson AJ, Krasnow SH, Spagnolo SV, Citron ML, Payne M, Fossieck BE Jr: Continuous intravenous infusion of morphine for severe dyspnea. South Med J 1991;84:229-234.
88. Wilson WC, Smedira NG, Fink C, McDowell JA, Luce J: Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. JAMA 1992;267:949-953.
89. Campbell ML, Bizek KS, Thill M. Patient responses during rapid terminal weaning from mechanical ventilation: A prospective study. Crit Care Med 1999;27:7377.
90. Morita T, Tsunoda J, Inoue S, Chihara S: Effects of high-dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Sympt Manage 2001;21:282-289.
91. McCarthy M, Lay M, Addington-Hall J: Dying from heart disease. J R Coll Phys Lond 1996;30:325-328.
92. Bleumink GS, Feenstra J, Sturkenboom MC, Stricker BH: Nonsteroidal anti-inflammatory drugs and heart failure. Drugs 2003;63:525-534.
93. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A: NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-1112.
94. Page J, Henry D: Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem. Arch Intern Med 2000;160:777-784.
95. Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW, Young JB: Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation 2000;102:2443-2456.
96. O'Connor CM, Joynt KE: Depression: Are we ignoring an important comorbidity in heart failure? J Am Coll Cardiol 2004;43:1550-1552.
97. Martensson J, Dracup K, Canary C, Fridlund B: Living with heart failure: Depression and quality of life in patients and spouses. J Heart Lung Transplant 2003;22:460-467.
98. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, Marshall J, Minshall S, Robinson S, Fisher ML, Potenza M, Sigler B, Baldwin C, Thomas SA: The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004;43:1542-1549.
99. Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Pignone M: Is this patient clinically depressed? JAMA 2002;287:1160-1170.
100. Doering LV, Dracup K, Caldwell MA, Moser DK, Erickson VS, Fonarow G, Hamilton M: Is coping style linked to emotional states in heart failure patients? J Card Fail 2004;10:344-349.
101. Guck TP, Elsasser GN, Kavan MG, Barone EJ: Depression and congestive heart failure. Congest Heart Fail 2003;9:163-169.
102. Callahan HE: Families dealing with advanced heart failure: A challenge and an opportunity. Crit Care Nurs Q 2003;26:230-243.
103. Sager MA, Franke T, Inouye SK, Landefeld CS, Morgan TM, Rudberg MA, Sebens H, Winograd CH: Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med 1996;156:645-652.
104. Stuart B, Alexander C, Arenalla C, Connor S, Herbst L, Jones D, Kinzbrunner B, Rousseau P, Ryndes T, Wohlfeiler M, Cody C, Buckley S: Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases, 2nd ed. Standards and Accreditation Committee. Arlington, VA: National Hospice Organization, 1996.
105. Hauptman PJ, Havranek EP: Integrating palliative care into heart failure care. Arch Intern Med 2005;165:374-378.
106. Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams LD, Tierney WM, Brater DC: Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001;111:513-520.
107. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG: Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 2003;42:1944-1951.
108. Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D: Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: Retrospective study. BMJ 2003;327:1141-1142.
109. Rich MW, Shore BL: Dobutamine for patients with end-stage heart failure in a hospice program? J Palliat Med 2003;6:93-97.
110. O'Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM: Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999;138:78-86.
111. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-1547.
112. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA; MOde Selection Trial Investigators: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-2937.
113. Rosanio S, Schwarz ER, Ahmad M, Jammula P, Vitarelli A, Uretsky BF, Birnbaum Y, Ware DL, Atar S, Saeed M: Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol 2005;96:710-717.
114. Braun MU, Rauwolf T, Zerm T, Schulze M, Schnabel A, Strasser RH: Long term biventricular resynchronisation therapy in advanced heart failure: Effect on neurohormones. Heart 2005;91:601-605.
115. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M: Biventricular pacing in heart failure: Back to basics in the pathophysiology of left bundle branch block to reduce the number of non-responders. Am J Cardiol 2003;91:55F-61F.
116. Jarcho JA: Resynchronizing ventricular contraction in heart failure. N Engl J Med 2005;352:1594-1597.
117. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004;141:835-838.
118. Saksena S, Madan N: Management of the patient with an implantable cardioverter-defibrillator in the third millennium. Circulation 2002;106:2642-2646.
119. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators: Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study. A randomized trial. JAMA 2006;295:165-171.
120. Brugada J, Berruezo A, Cuesta A, Osca J, Chueca E, Fosch X, Wayar L, Mont L: Nonsurgical transthoracic epicardial radiofrequency ablation: An alternative in incessant ventricular tachycardia. J Am Coll Cardiol 2003;41:2036-2043.
121. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ; PainFREE Rx II Investigators: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591-2596.
122. Sears SF, Sowell LV, Kuhl EA, Handberg EM, Kron J, Aranda JM Jr, Conti JB: Quality of death: Implantable cardioverter defibrillators and proactive care. Pacing Clin Electrophysiol 2006;29:637-642.
123. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ: The cost effectiveness of implantable cardioverter-defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:2310-2318.
124. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
125. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.
126. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS; Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators: Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006;113:2810-281
127. Dunbar SB, Warner CD, Purcell JA: Internal cardioverter defibrillator device discharge: Experiences of patients and family members. Heart Lung 1993;22:494-501.
128. Braun TC, Hagen NA, Hatfield RE, Wyse DG: Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage 1999;18:126-131.
129. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F: Adverse events with transvenous implantable cardioverter-defibrillators: A prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998;98:663-670.
130. Maisel WH: Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 2006;295:1929-1934.
131. O'Brien MC, Langberg J, Valderrama AL, Kirkendoll K, Romeiko N, Dunbar SB: Implantable cardioverter defibrillator storm: Nursing care issues for patients and families. Crit Care Nurs Clin North Am 2005;17:9-16.
132. Schuster PM, Phillips S, Dillon DL, Tomich PL: The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator. Rehabil Nurs 1998;23:3037.
133. Goodman M, Hess B: Could implantable cardioverter defibrillators provide a human model supporting the learned helplessness theory of depression? Gen Hosp Psychiatry 1999;21:382-385.
134. Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP, Behrens S: Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004;27:321-326.
135. Hamner M, Hunt N, Gee J, Garrell R, Monroe R: PTSD and automatic implantable cardioverter defibrillators. Psychosomatics 1999;40:82-85.
136. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 2004;33:176-182.
137. Prudente LA: Psychological disturbances, adjustment, and the development of phantom shocks in patients with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2005;20:288-293.
138. Berger JT: The ethics of deactivating implanted cardioverter defibrillators. Ann Int Med 2005;142:631-634.
139. Nambisan V, Chao D: Dying and defibrillation: A shocking experience. Palliat Med 2004;18:482-483.
140. Ballentine JM: Pacemaker and defibrillator deactivation in competent hospice patients: An ethical consideration. Am J Hosp Palliat Care 2005;22:14-19.
141. Harrington MD, Luebke DL, Lewis WR, Auliso MP, Johnson NJ: Implantable cardioverter defibrillator (ICD) at end of life #112. J Palliat Med 2005;8:1056-1057.
142. Hauptman PJ: Palliation in heart failure: When less and more are more. Am J Hospice Pall Med 2006;23:150-152.
143. Paola FA, Walker RM: Deactivating the implantable cardioverter- defibrillator: A biofixture analysis. South Med J 2000;93:20-23.
144. Morrison LJ, Sinclair CT: Next of kin responses and do-not-resuscitate implications for implantable cardioverter defibrillators. Ann Intern Med 2005;142:676-677.
145. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
146. Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, Aaronson K, Richenbacher W, van Meter C, Nelson K, Weinberg A, Watson J, Rose EA, Moskowitz AJ: Left ventricular assist devices as permanent heart failure therapy. The price of progress. Ann Surg 2003;238:577-583.
147. Birks EJ, Yacoub MH, Banner NR, Khaghani A: The role of bridge to transplantation: Should LVAD patients be transplanted? Curr Opin Cardiol 2004;19:148-153.
148. Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, Banner NR, Khaghani A: Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004;23:964-969.
149. Bunzel B, Laederach-Hofmann K, Wieselthaler GM, Roethy W, Drees G. Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: Evaluation of patients and partners. Transplant Proc 2005;37:1365-1368.
150. National Heart, Lung and Blood Institute Working Group: Next generation ventricular assist devices for destination therapy. 〈www.nhlbi.nih.gov/ meetings/workshops/nextgen-vads.htm〉 (Last accessed June 20, 2006).
151. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR: Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: A meta-analysis. JAMA 2004;291:1358-1367.
152. McAlister FA, Stewart S, Ferrua S, McMurray JJJV: Multidisciplinary strategies for the management of heart failure patients at high risk for admission. J Am Coll Cardiol 2004;44:810-819.
153. Laramee AS, Levinsky SK, Sargent J, Ross R, Callas P: Case management in a heterogeneous congestive heart failure population: A randomized controlled trial. Arch Intern Med 2003;163:809-817.
154. Stuart B: Transition management: A new paradigm for home care of the chronically ill near the end of life. Home Health Care Mgmt Practice 2003;15:126-135.
155. Ciemins EL, Stuart B, Gerber R, Newman JM, Bauman M: An evaluation of the Advanced Illness Management (AIM) Program: Increasing hospice utilization in the San Francisco Bay Area. J Palliat Med (in press).
156. GESICA Investigators: Randomised trial of telephone intervention in chronic heart failure: DIAL Trial. BMJ 2005;331:425.
157. Benatar D, Bondmass M, Ghitelman J, Avitall B: Outcomes of chronic heart failure. Arch Intern Med 2003;163:347-352.